Table 1.
Antibiotic susceptibilities of the Acinetobacter baumannii strains in this study.
| Case | Origin (Specimen) | Isolation date | Hospital unit | Antimicrobial susceptibility |
|---|---|---|---|---|
| Case 1 | Urine | 05/09/2005 | Adult ICU | none |
| Case 2 | Tracheal secretion | 11/01/2006 | Adult ICU | ART |
| Blood | 12/01/2006 | Adult ICU | SAM, ART | |
| Case 3 | Blood | 19/01/2006 | Adult ICU | SAM |
| Catheter tip | 19/01/2006 | Adult ICU | SAM | |
| Catheter tip | 19/01/2006 | Adult ICU | SAM | |
| Case 4 | Abdominal secretion | 20/01/2006 | Adult ICU | SAM |
| Tracheal secretion | 24/01/2006 | Adult ICU | SAM | |
| Case 5 | Tracheal secretion | 31/01/2006 | Adult ICU | SAM |
| Blood | 02/02/2006 | Adult ICU | SAM, FEP | |
| Case 6 | Vaginal secretion | 10/02/2006 | Adult ICU | SAM, FEP |
Table captions: All strains were tested by Kirby Bauer method for: PIP, piperacillin; TZP, piperacillin/tazobactam; CAZ, ceftazidime; CTX, cefotaxime; FEP, cefepime; ATM, aztreonam; IMP, imipenem; MEM, meropenem; CIP, ciprofloxacin; AMK, Amikacin; GEN, Gentamicin; SXT, Trimethoprim/Sulfamethoxazole; ART, aztreonam; SAM, ampicillin/sulbactam; ICU, intensive care unit.